Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1264-1271

  Haagmans, Bart L ^a   Van Rooij, Eugene M A ^b   Dubelaar, Mark ^a   Kimman, Tjeerd G ^c   Horzinek, Marian C ^a   Schijns, Virgil E C J ^a   Bianchi, Andre T J ^b  

^a Department of Infectious Diseases and Immunology   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

DNA vaccination; Glycoprotein D; Pseudorabies virus

Indexed keywords

DNA VACCINE; GLYCOPROTEIN D; NEUTRALIZING ANTIBODY; PLASMID DNA; PSEUDORABIES VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; SWINE; VACCINATION; VIRUS EXCRETION; VIRUS INFECTION; VIRUS VIRULENCE;

ANIMALS; CLONING, MOLECULAR; FEMALE; HERPESVIRUS 1, SUID; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; PSEUDORABIES; SWINE; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0033525597     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00349-1     Document Type: Article

References (39)

1. Gustafson DP. Pseudorabies. In: Leman AD, Straw B, Glock RD, Mengelin WL, Penny RNC, Schull ES, editors. Disease of swine. Ames, Iowa: Iowa State University Press, 1986. p. 274-89.
2. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
3. Williams R.S., Johnston S.A., Riedy M., DeVit M.J., McElligott S.G., Sanford J.C. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA. 88:1991;2726-2730.
4. Tang D., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
5. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Lui M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
6. Xiang Z., Ertl H.C.J. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
7. Manickan E., Rouse R.J., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T-lymphocytes. J Immunol. 155:1995;259-265.
8. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis. 173:1996;800-807.
9. Martins L.P., Lau L.L., Asano M.S., Ahmed R. DNA vaccination against persistent viral infection. J Virol. 69:1995;2574-2582.
10. Yokoyama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol. 69:1995;2684-2688.
11. González Armas J.C., Morello C.S., Cranmer L.D., Spector D.H. DNA immunization confers protection against murine cytomegalovirus infection. J Virol. 70:1996;7921-7928.
12. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papilloma virus with a polynucleotide vaccine. J Infect Dis. 173:1996;314-320.
13. Cox G.J., Zamb T.J., Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 67:1993;5664-5667.
14. Yasutomi Y., Robinson H.L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J.I., Voss G., Manson K., Wyand M., Letvin N.L. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol. 70:1996;678-681.
15. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol. 70:1996;3978-3991.
16. Marchioli C.C., Yancey R.J., Petrovskis E.A., Timmins J.G., Post L.E. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine; expression by vaccinia virus and chinese hamster ovary cells. J Virol. 61:1987;3977-3982.
17. Ishii H., Kobayashi Y., Kuroki M., Kodama Y. Protection of mice from lethal infection with Aujesky's disease virus by immunisation with purified gVI. J Gen Virol. 69:1988;1411-1414.
18. Riviere M., Tartaglia J., Perkus M.E., Norton E.K., Molnar Bongermino C., Lacoste F., Duret C., Desmettre P., Paoletti E. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J Virol. 66:1992;3424-3434.
19. Kimman T.G. Comparative efficacy of three doses of the genetically engineered Aujesky's disease virus vaccine strain 783 in pigs with maternal antibodies. Vaccine. 10:1992;363-365.
20. Peeters B., Bouma A., de Bruin T., Moormann R., Gielkens A., Caiman T. Non transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines. Vaccine. 12:1994;375-380.
21. Schijns V.E.C.J., Haagmans B.L., Horzinek M.C. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J Immunol. 155:1995;2525-2532.
22. Raugh L.F., Mettenleiter T.C. Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol. 65:1991;5348-5356.
23. Peeters B., Pol J., Gielkens A., Moorman R. Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol. 67:1993;170-177.
24. Eliot M., Fargeaud D., L'Haridon R., Toma B. Identification of pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Arch Virol. 99:1988;45-56.
25. Wathen L.M.K., Platt K.B., Wathen M.W., Vandeusen R.A., Whetstone C.A., Pirtle E.C. Production and characterization of monoclonal antibody directed against pseudorabies virus. Virus Res. 4:1985;19-29.
26. McFerran J.B., Dow C. Studies on immunisation of pigs with the Bartha strain of Aujeszky disease virus. Res Vet Sci. 19:1975;17-22.
27. Peeters B., de Wind N., Hooisma M., Wagenaar F., Gielkens A., Moormann R. Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion. J Virol. 66:1992;894-905.
28. Kimman T.G., De Bruin T.G.M., Voermans J.J.M., Peeters B.P.H., Bianchi A.T.J. Development and antigen specificity of the lymphoproliferation response of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses. Immunology. 86:1995;372-378.
29. Bitsch V., Eskildsen M. A comparative examination of swine sera for antibody to Aujesky virus with the conventional and modified virus serum neutralization test and a modified complement fixation test. Acta Vet Scan. 17:1976;142-145.
30. Gerdts V., Jons A., Makoschey B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol. 78:1997;2139-2146.
31. Vannier P., Hutet E., Bourgueil E., Cariolet R. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vet Micr. 29:1991;213-223.
32. Monteil M., Le Potier M.F., Guillotin J., Cariolet R., Houdayer C., Eliot M. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet Res. 27:1996;443-452.
33. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol. 70:1996;6119-6125.
34. Hengge U.R., Walker P.S., Vogel J.C. Expression of naked DNA in human, pig, and mouse skin. J Clin Invest. 97:1996;2911-2916.
35. Zuckermann F.A., Zsak L., Mettenleiter T., Ben-Porat T. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T-lymphocytes. J Virol. 64:1990;802-812.
36. Kimman T.G., De Bruin T.G.M., Voermans J.J.M., Bianchi A.T.J. Cell- mediated immunity to pseudorabies virus: cytolytic effector cells with characteristics of lymphokine-activated killer cells lyse virus-infected and glycoprotein gB- and gC- transfected L14 cells. J Gen Virol. 77:1996;987-990.
37. Schijns V.E.C.J., Van Der Neut R., Haagmans B.L., Bar D.R., Schellekens H., Horzinek M.C. Tumour necrosis factor-α, interferon-γ and interferon-β exert antiviral activity in nervous tissue cells. J Gen Virol. 72:1991;809-815.
38. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
39. Chow Y.-H., Huang W.L., Chi W.-K., Chu Y.-D., Tao M.-H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol. 71:1997;169-178.